EBOLA OUTBREAK
Experimental drug fights Ebola's cousin Marburg, even after symptom onset
Scientists have reported that Tekmira Pharmaceuticals Corp.'s experimental drug candidate TKM-Marburg (NP-718mLNP) was able to prevent monkeys from becoming seriously ill after Marburg virus infection, even when treatment was not started until the animals showed signs of viremia.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.